(0.00%) 5 187.67 points
(0.44%) 39 056 points
(-0.18%) 16 303 points
(1.08%) $79.23
(-1.13%) $2.18
(-0.35%) $2 316.00
(0.07%) $27.56
(-0.36%) $984.80
(0.11%) $0.930
(0.10%) $10.91
(0.09%) $0.800
(0.21%) $91.63
Quarter results today
(bmo 2024-05-08)
Expected move: +/- 6.79%
@ $8.22
Utstedt: 14 feb 2024 @ 15:30
Avkastning: 23.84%
Forrige signal: feb 13 - 15:30
Forrige signal:
Avkastning: -2.26 %
Live Chart Being Loaded With Signals
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients...
Stats | |
---|---|
Dagens volum | 621 967 |
Gjennomsnittsvolum | 819 065 |
Markedsverdi | 529.44M |
EPS | $0 ( 2024-02-28 ) |
Neste inntjeningsdato | ( $-0.190 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.88 |
ATR14 | $0.0160 (0.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Novack Jeffrey Adam | Sell | 1 905 | Common Stock |
2024-04-24 | Novack Jeffrey Adam | Sell | 0 | Common Stock |
2024-04-24 | Novack Jeffrey Adam | Sell | 2 385 | Employee Stock Option (right to buy) |
2024-04-24 | Novack Jeffrey Adam | Sell | 2 150 | Employee Stock Option (right to buy) |
2024-05-01 | Jain Abhishek | Sell | 7 371 | Common Stock |
INSIDER POWER |
---|
8.63 |
Last 100 transactions |
Buy: 1 531 623 | Sell: 918 597 |
Volum Korrelasjon
CareDx Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
INFI | 0.962 |
BAND | 0.958 |
NKTR | 0.955 |
FULC | 0.954 |
INGN | 0.953 |
ORGS | 0.953 |
UPLD | 0.949 |
JAGX | 0.941 |
MICS | 0.936 |
GOODM | 0.934 |
10 Mest negative korrelasjoner | |
---|---|
TIG | -0.918 |
TYHT | -0.915 |
MYRG | -0.913 |
SGEN | -0.911 |
OPCH | -0.906 |
PPYAU | -0.898 |
APEN | -0.889 |
RELY | -0.889 |
KNBE | -0.882 |
ALTR | -0.88 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
CareDx Inc Korrelasjon - Valuta/Råvare
CareDx Inc Økonomi
Annual | 2023 |
Omsetning: | $280.32M |
Bruttogevinst: | $175.87M (62.74 %) |
EPS: | $-3.54 |
FY | 2023 |
Omsetning: | $280.32M |
Bruttogevinst: | $175.87M (62.74 %) |
EPS: | $-3.54 |
FY | 2022 |
Omsetning: | $321.79M |
Bruttogevinst: | $209.58M (65.13 %) |
EPS: | $-1.440 |
FY | 2021 |
Omsetning: | $296.40M |
Bruttogevinst: | $199.01M (67.14 %) |
EPS: | $-0.582 |
Financial Reports:
No articles found.
CareDx Inc
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution; Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.